1. Home
  2. BWAY

as of 11-12-2026 3:38pm EST

$10.25
$1.00
-8.85%
Stocks Health Care Medical/Dental Instruments Nasdaq

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Founded: 2003 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 468.5M IPO Year: 2011
Target Price: $19.27 AVG Volume (30 days): 101.5K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $10.21 - $26.63 Next Earning Date: 11-10-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 33.61% Revenue Growth (next year): 23.01%
P/E Ratio: 81.98 Index: N/A
Free Cash Flow: N/A FCF Growth: -69.11%

Share on Social Networks: